Ticker Scorecard - EMBC Basics Company: Embecta Corp. IPO Date: April 1, 2022 Sector: Healthcare Industry: Drug Manufacturers - Specialty and Generic Market Cap: $819.7M Activated in VL: True Average Daily Range Avg Daily Range: $0.47 | 2.13% Avg Daily Range (30 D): $0.44 | 2.48% Avg Daily Range (90 D): $0.37 | 2.15% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .3M Avg Daily Volume (90 D): .3M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 46 Avg Trade Size (Sh.) (90 D): 49 Institutional Trades Total Inst.Trades: 1,198 Avg Inst. Trade: $2.35M Avg Inst. Trade (30 D): $1.38M Avg Inst. Trade (90 D): $1.43M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.67M Avg Closing Trade (30 D): $1.43M Avg Closing Trade (90 D): $1.37M Avg Closing Volume: 112.03K     News Feb 18, 2025 @ 10:00 PM embecta to Participate at the J.P. Morgan Global L... Source: N/A Feb 6, 2025 @ 3:24 PM Becton Dickinson Q1 Earnings: Revenue And EPS Beat... Source: Vandana Singh Feb 6, 2025 @ 11:00 AM embecta Announces Quarterly Cash Dividend Source: N/A Feb 3, 2025 @ 6:06 PM Activist Starboard Value Pushes Becton Dickinson T... Source: Vandana Singh Jan 23, 2025 @ 10:00 PM embecta to Report Fiscal First Quarter 2025 Financ... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $1.36 $.25 $1.36 Diluted EPS $1.34 $.24 $1.34 Revenue $ 1.12B $ 286.1M $ 1.12B Gross Profit $ 735.2M $ 173.8M $ 735.2M Net Income / Loss $ 78.3M $ 14.6M $ 78.3M Operating Income / Loss $ 166.8M $ 26.2M $ 166.8M Cost of Revenue $ 387.9M $ 112.3M $ 387.9M Net Cash Flow $ -53.5M $ -10M $ -53.5M PE Ratio 10.52